Ana Guijarro Hernandez

Title(s)Postdoctoral Scholar, Physiology
SchoolSchool of Medicine
Address600 16th Street, #N416
San Francisco CA 94158
Emailana.guijarrohernandez@ucsf.edu
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-1061-7744 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Navarra, Pamplona, SpainPh.D.12/2023Applied Medicine and Biomedicine
    University of Navarra, Pamplona, SpainM.Sc.09/2019 Biomedical Research
    University of Navarra, Pamplona, SpainB.S.06/2018Biochemistry

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Myeloproliferative Neoplasm-like Mutations of Calreticulin Induce Phenotypes Associated with Calreticulin Dysfunction in C. elegans. Int J Mol Sci. 2024 Oct 29; 25(21). Guijarro-Hernández A, Hurtado C, Urizar-Compains E, Ezcurra B, Galiana-Sáenz A, Baquero E, Cabello J, Vizmanos JL. PMID: 39519157; PMCID: PMC11546369.
      View in: PubMed   Mentions:
    2. CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia. Cancers (Basel). 2024 Apr 16; 16(8). Guijarro-Hernández A, Hurtado C, Larráyoz MJ, Calasanz MJ, Vizmanos JL. PMID: 38672593; PMCID: PMC11048154.
      View in: PubMed   Mentions:
    3. Transcriptomic comparison of bone marrow CD34?+?cells and peripheral blood neutrophils from ET patients with JAK2 or CALR mutations. BMC Genom Data. 2023 Aug 07; 24(1):40. Guijarro-Hernández A, Vizmanos JL. PMID: 37550636; PMCID: PMC10408115.
      View in: PubMed   Mentions:
    4. Monitoring Caenorhabditis elegans molting in a conventional luminometer. MethodsX. 2023; 10:102235. Guijarro-Hernández A, Hurtado C, Martínez-Irujo JJ, Vizmanos JL. PMID: 37346480; PMCID: PMC10279910.
      View in: PubMed   Mentions:
    5. Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model. Cells. 2023 Jan 02; 12(1). Guijarro-Hernández A, Eder-Azanza L, Hurtado C, Navarro-Herrera D, Ezcurra B, Novo FJ, Cabello J, Vizmanos JL. PMID: 36611979; PMCID: PMC9818371.
      View in: PubMed   Mentions:
    6. Optimizing simple calreticulin upregulation strategies in Caenorhabditis elegans. Biol Methods Protoc. 2023; 8(1):bpac036. Guijarro-Hernández A, Hurtado C, Vizmanos JL. PMID: 36686858; PMCID: PMC9846421.
      View in: PubMed   Mentions:
    7. A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms. Cancers (Basel). 2021 Feb 26; 13(5). Guijarro-Hernández A, Vizmanos JL. PMID: 33652860; PMCID: PMC7956519.
      View in: PubMed   Mentions:
    Ana's Networks
    Concepts (19)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _